ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST

Clinical trial NCT05366816 · RECRUITING

Trial details

NCT number: NCT05366816
Sponsor: University of Miami
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2023-10-17
Primary completion: 2026-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.